Topics

Congratulations to our cross-functional deal team on winning the 2019 #ScripAwards Financing Deal of the Year for our five-part immuno-oncology collaboration with @InnatePharma. For information on partnering with us: http://bit.ly/2QDn7Cz pic.twitter.co

15:48 EST 4 Dec 2019 | AztraZeneca

Congratulations to our cross-functional deal team on winning the 2019 Financing Deal of the Year for our five-part immuno-oncology collaboration with . For information on partnering with us: http://bit.ly/2QDn7Cz 

Original Article: Congratulations to our cross-functional deal team on winning the 2019 #ScripAwards Financing Deal of the Year for our five-part immuno-oncology collaboration with @InnatePharma. For information on partnering with us: http://bit.ly/2QDn7Cz pic.twitter.co

NEXT ARTICLE

More From BioPortfolio on "Congratulations to our cross-functional deal team on winning the 2019 #ScripAwards Financing Deal of the Year for our five-part immuno-oncology collaboration with @InnatePharma. For information on partnering with us: http://bit.ly/2QDn7Cz pic.twitter.co"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...